A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 in Pediatric and Young Adult Participants With KCNT1-related Epilepsy
Clinical trial NCT07600736 · RECRUITING
Trial details
- NCT number
- NCT07600736
- Sponsor
- Actio Biosciences, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-18
- Primary completion
- 2027-01-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.